As attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaxfab Enterprises reported standalone revenue from operations of Rs 1,566.29 lakhs in Q3 FY26, down sharply from Rs 4,576.84 lakhs in the same quarter last year. Standalone other income was negative at Rs (336.68) lakhs, dragging total revenue to Rs 1,229.61 lakhs and pushing the company into a net loss of Rs (323.52) lakhs versus a profit of Rs 641.33 lakhs a year ago. Consolidated results were better, showing a small net profit of Rs 22.98 lakhs, but on a similarly weak revenue base. The statutory auditor (Chandabhoy & Jassoobhoy) issued a qualified opinion, flagging that books were prepared on a going-concern basis but key records from previous management were unavailable, unsecured loans were given/received without agreements, third-party confirmations were missing, no gratuity provision or actuarial valuation was made, and no impairment assessment was carried out under Ind AS 109.
Investors should treat these results with caution — the standalone business swung to a clear loss, revenue collapsed year-on-year, and the auditor raised multiple qualifications regarding missing records and weak internal controls, which together raise serious governance and going-concern concerns and could weigh negatively on the stock.